Works matching IS 17762596 AND DT 2018 AND VI 13 AND IP 3
Results: 12
Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Avelumab: A Review in Metastatic Merkel Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic and Predictive Factors for Renal Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting BCL-2 in Hematologic Malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article